Author

R. S. Pandurangi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. Karwa· 1 shared A. Luchman· 1 shared C. Ma· 1 shared D. Shah· 1 shared l. Forrest· 1 shared O. Cseh· 1 shared R. Paulmurugan· 1 shared S. Senedheera· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Karwa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 3, 2023

Restoration of the Lost Human Beta Defensin (hBD-1) in Cancer as a Strategy to Improve the Efficacy of Chemotherapy

R. S. Pandurangi, R. Paulmurugan, S. Tillai

This study shows that restoring hBD-1 in TNBC cells activates apoptosis pathways, sensitizing them to chemotherapy and reducing tumor volume in a mouse model.

DOI 10.1101/2023.04.03.535411

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 20, 2021

Rational Drug Design of Targeted and Enzyme Cleavable Vitamin E Analogs as Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of Cardiotoxicity of Doxorubicin.

R. S. Pandurangi, O. Cseh, A. Luchman…·l. Forrest

The paper designs and evaluates Vitamin E analogs with targeting and cleavable features to reduce Doxorubicin cardiotoxicity in cancer treatment.

DOI 10.1101/2021.05.20.445072

ratexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 13, 2021

Medicago Sativa Defensin 1 (MsDef1), A Natural Tumor Targeted Sensitizer for Improving Chemotherapy: Translation from Anti-Fungal Agent to Potential Anti-Cancer Agent

R. S. Pandurangi, D. Shah, A. Karwa, U. S. Sagaram

This paper shows that MsDef1, a plant defensin, sensitizes drug-resistant cancer cells to chemotherapy by targeting two tumor-specific pathways.

DOI 10.1101/2021.02.13.431112

proteomicsexperimental assay

𝕏 PostBluesky